Two prominent researchers at UC Davis are under a microscope for their work in stem-cell biotechnology. The pair from University of California, Davis was awarded close to $4 million in funding to improve biotechnology intended for physicians studying stem cell treatments.

University of Idaho researchers will soon have a new tool for understanding the world at the molecular level, thanks to a grant from the MJ Murdock Charitable Trust and a major gift from a private donor.

Problem: Research into gastrointestinal diseases often presents clinicians and researchers with difficulties in terms of collecting samples from patients for analysis. The very nature of the gastrointestinal tract makes it relatively inaccessible for simple, effective sampling. Current processes require the patient to collect samples of stool, have a rectal swab taken or a tissue biopsy during endoscopy. Each of these methods is not without its problems, whether for the patient, the clinician, or the researcher.

Study in mice could lead to better treatment and prevention for humans.

A spit test may one day be able to diagnose autism according to researchers at Clarkson University and the State University of New York at Plattsburgh.

While debate about recreational marijuana use continues, researchers are investigating the effectiveness of cannabis for treating pain, spasticity, and a host of other medical problems. In a symposium organized by the McGill University Health Centre (MUHC) as part of the 2015 American Association for the Advancement of Science Annual Meeting held this week in San Jose, California, world-renowned experts from North America and the U.K. share their perspectives on the therapeutic potential of medical cannabis and explore the emerging science behind it.

A recently published study in the Journal of the American Medical Association Pediatrics, based in part on research from the Children’s Hospital of Michigan part of the Detroit Medical Center, shows that oral antibiotics are just as effective as those delivered intravenously to children struggling with osteomyelitis.  

It's a wonder new medications are ever developed at all. Taking a new drug from promising molecule to marketable product can cost upwards of a billion dollars and take a decade or more to move from clinical trials to approval. And the overall failure rate hovers near 95 percent.

Step-by-step observations will help scientists enhance bone-marrow transplants.

Researchers at Duke University report the first lab-grown, contracting human muscle, which could revolutionize drug discovery and personalized medicine.